TY - JOUR
T1 - The Initial Symptom and Motor Progression in Spinocerebellar Ataxias
AU - Luo, Lan
AU - Wang, Jie
AU - Lo, Raymond Y.
AU - Figueroa, Karla P.
AU - Pulst, Stefan M.
AU - Kuo, Pei Hsin
AU - Perlman, Susan
AU - Wilmot, George
AU - Gomez, Christopher M.
AU - Schmahmann, Jeremy D.
AU - Paulson, Henry
AU - Shakkottai, Vikram G.
AU - Ying, Sarah H.
AU - Zesiewicz, Theresa
AU - Bushara, Khalaf
AU - Geschwind, Michael
AU - Xia, Guangbin
AU - Subramony, S. H.
AU - Ashizawa, Tetsuo
AU - Kuo, Sheng Han
N1 - Funding Information:
Acknowledgements This study was supported in part by the NINDS K08 NS083738, Louis V. Gerstner Jr. Scholarship, Parkinson Disease Foundation, Rare Disease Clinical Research Network (RDCRN) (RC1NS068897), Jiangsu Government Scholarship for Overseas Studies, Qing Lan Project, and the Key Discipline Development Project (JX10617801) of Jiangsu Province, China.
Funding Information:
Funding NINDS K08 NS083738, Louis V. Gerstner Jr. Scholarship, American Brain Research Training Fellowship, Parkinson Disease Foundation, American Parkinson’s Disease Association, Rare Disease Clinical Research Network (RDCRN) (RC1NS068897), International Essential Tremor Foundation, and NIEHS pilot grant ES009089, the Smart Foundation, Jiangsu Government Scholarship for Overseas Studies, Qing Lan Project, and the Key Discipline Development Project (JX10617801) of Jiangsu Province, China.
Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2017/6/1
Y1 - 2017/6/1
N2 - The aim of this study is to determine whether the initial symptom associates with motor progression in spinocerebellar ataxias (SCAs). SCAs are clinically heterogeneous and the initial presentation may represent different subtypes of SCA with different motor progression. We studied 317 participants with SCAs1, 2, 3, and 6 from the Clinical Research Consortium for SCAs (CRC-SCA) and repeatedly measured the severity of ataxia for 2 years. SCA patients were divided into gait-onset and non-gait-onset (speech, vision, and hand dexterity) groups based on the initial presentation. In addition to demographic comparison, we employed regression models to study ataxia progression in these two groups after adjusting for age, sex, and pathological CAG repeats. The majority of SCA patients had gait abnormality as an initial presentation. The pathological CAG repeat expansions were similar between the gait-onset and non-gait-onset groups. In SCA1, gait-onset group progressed slower than non-gait-onset group, while gait-onset SCA6 group progressed faster than their counterpart. In addition, the disease presented 9 years later for SCA2 gait-onset group than non-gait-onset group. Initial symptoms of SCA3 did not influence age of onset or disease progression. The initial symptom in each SCA has a different influence on age of onset and motor progression. Therefore, gait and non-gait-onset groups of SCAs might represent different subtypes of the diseases.
AB - The aim of this study is to determine whether the initial symptom associates with motor progression in spinocerebellar ataxias (SCAs). SCAs are clinically heterogeneous and the initial presentation may represent different subtypes of SCA with different motor progression. We studied 317 participants with SCAs1, 2, 3, and 6 from the Clinical Research Consortium for SCAs (CRC-SCA) and repeatedly measured the severity of ataxia for 2 years. SCA patients were divided into gait-onset and non-gait-onset (speech, vision, and hand dexterity) groups based on the initial presentation. In addition to demographic comparison, we employed regression models to study ataxia progression in these two groups after adjusting for age, sex, and pathological CAG repeats. The majority of SCA patients had gait abnormality as an initial presentation. The pathological CAG repeat expansions were similar between the gait-onset and non-gait-onset groups. In SCA1, gait-onset group progressed slower than non-gait-onset group, while gait-onset SCA6 group progressed faster than their counterpart. In addition, the disease presented 9 years later for SCA2 gait-onset group than non-gait-onset group. Initial symptoms of SCA3 did not influence age of onset or disease progression. The initial symptom in each SCA has a different influence on age of onset and motor progression. Therefore, gait and non-gait-onset groups of SCAs might represent different subtypes of the diseases.
KW - Cerebellum
KW - Neurodegeneration
KW - Spinocerebellar ataxias
KW - Subtypes
UR - http://www.scopus.com/inward/record.url?scp=85027875308&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027875308&partnerID=8YFLogxK
U2 - 10.1007/s12311-016-0836-3
DO - 10.1007/s12311-016-0836-3
M3 - Article
C2 - 27848087
AN - SCOPUS:85027875308
VL - 16
SP - 615
EP - 622
JO - Cerebellum
JF - Cerebellum
SN - 1473-4222
IS - 3
ER -